perylene has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaewtunjai, N; Lee, TR; Lojanapiwat, B; Summart, R; Tuntiwechapikul, W; Wongnoppavich, A | 1 |
1 other study(ies) available for perylene and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Telomerase Inhibition, Telomere Shortening, and Cellular Uptake of the Perylene Derivatives PM2 and PIPER in Prostate Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cellular Senescence; Humans; Male; PC-3 Cells; Perylene; Prostatic Neoplasms, Castration-Resistant; Telomerase; Telomere Shortening | 2019 |